387 related articles for article (PubMed ID: 11016962)
21. Balanced immunity. Would killing some T cells slow the progress of AIDS?
Rennie J
Sci Am; 1993 May; 268(5):22-4. PubMed ID: 8097592
[No Abstract] [Full Text] [Related]
22. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.
Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T
Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435
[TBL] [Abstract][Full Text] [Related]
23. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.
Moroz A; Eppolito C; Li Q; Tao J; Clegg CH; Shrikant PA
J Immunol; 2004 Jul; 173(2):900-9. PubMed ID: 15240677
[TBL] [Abstract][Full Text] [Related]
24. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.
Fehniger TA; Suzuki K; Ponnappan A; VanDeusen JB; Cooper MA; Florea SM; Freud AG; Robinson ML; Durbin J; Caligiuri MA
J Exp Med; 2001 Jan; 193(2):219-31. PubMed ID: 11208862
[TBL] [Abstract][Full Text] [Related]
25. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.
Waldmann TA
Nat Rev Immunol; 2006 Aug; 6(8):595-601. PubMed ID: 16868550
[TBL] [Abstract][Full Text] [Related]
26. A new role for PGRP-S (Tag7) in immune defense: lymphocyte migration is induced by a chemoattractant complex of Tag7 with Mts1.
Dukhanina EA; Lukyanova TI; Romanova EA; Guerriero V; Gnuchev NV; Georgiev GP; Yashin DV; Sashchenko LP
Cell Cycle; 2015; 14(22):3635-43. PubMed ID: 26654597
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-15 and the regulation of lymphoid homeostasis.
Lodolce J; Burkett P; Koka R; Boone D; Chien M; Chan F; Madonia M; Chai S; Ma A
Mol Immunol; 2002 Dec; 39(9):537-44. PubMed ID: 12431387
[TBL] [Abstract][Full Text] [Related]
28. The emerging role of IL-15 in NK-cell development.
Liu CC; Perussia B; Young JD
Immunol Today; 2000 Mar; 21(3):113-6. PubMed ID: 10689297
[No Abstract] [Full Text] [Related]
29. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases.
Waldmann T
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S161-7. PubMed ID: 12110135
[TBL] [Abstract][Full Text] [Related]
30. IL-15 in the life and death of lymphocytes: immunotherapeutic implications.
Waldmann TA
Trends Mol Med; 2003 Dec; 9(12):517-21. PubMed ID: 14659465
[No Abstract] [Full Text] [Related]
31. Lymphocyte electrotaxis in vitro and in vivo.
Lin F; Baldessari F; Gyenge CC; Sato T; Chambers RD; Santiago JG; Butcher EC
J Immunol; 2008 Aug; 181(4):2465-71. PubMed ID: 18684937
[TBL] [Abstract][Full Text] [Related]
32. Fueling regulation: IL-2 keeps CD4+ Treg cells fit.
Maloy KJ; Powrie F
Nat Immunol; 2005 Nov; 6(11):1071-2. PubMed ID: 16239920
[No Abstract] [Full Text] [Related]
33. Interleukin-2 modulatory effects on the functional activity of human mononuclear cells in vitro.
Shirshev SV; Zamorina SA; Orlova EG; Timganova VP
Dokl Biol Sci; 2009; 429():508-10. PubMed ID: 20170059
[No Abstract] [Full Text] [Related]
34. Cell death and immunity.
Qreen DR
Science; 1995 Aug; 269(5225):861-2. PubMed ID: 17778745
[No Abstract] [Full Text] [Related]
35. Biological effects of IL-15 on immune cells and its potential for the treatment of cancer.
Zhang S; Zhao J; Bai X; Handley M; Shan F
Int Immunopharmacol; 2021 Feb; 91():107318. PubMed ID: 33383444
[TBL] [Abstract][Full Text] [Related]
36. CAR-T cell therapy: current limitations and potential strategies.
Sterner RC; Sterner RM
Blood Cancer J; 2021 Apr; 11(4):69. PubMed ID: 33824268
[TBL] [Abstract][Full Text] [Related]
37. CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
Jin L; Tao H; Karachi A; Long Y; Hou AY; Na M; Dyson KA; Grippin AJ; Deleyrolle LP; Zhang W; Rajon DA; Wang QJ; Yang JC; Kresak JL; Sayour EJ; Rahman M; Bova FJ; Lin Z; Mitchell DA; Huang J
Nat Commun; 2019 Sep; 10(1):4016. PubMed ID: 31488817
[TBL] [Abstract][Full Text] [Related]
38. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Neelapu SS; Locke FL; Bartlett NL; Lekakis LJ; Miklos DB; Jacobson CA; Braunschweig I; Oluwole OO; Siddiqi T; Lin Y; Timmerman JM; Stiff PJ; Friedberg JW; Flinn IW; Goy A; Hill BT; Smith MR; Deol A; Farooq U; McSweeney P; Munoz J; Avivi I; Castro JE; Westin JR; Chavez JC; Ghobadi A; Komanduri KV; Levy R; Jacobsen ED; Witzig TE; Reagan P; Bot A; Rossi J; Navale L; Jiang Y; Aycock J; Elias M; Chang D; Wiezorek J; Go WY
N Engl J Med; 2017 Dec; 377(26):2531-2544. PubMed ID: 29226797
[TBL] [Abstract][Full Text] [Related]
39. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages.
Gautier EL; Shay T; Miller J; Greter M; Jakubzick C; Ivanov S; Helft J; Chow A; Elpek KG; Gordonov S; Mazloom AR; Ma'ayan A; Chua WJ; Hansen TH; Turley SJ; Merad M; Randolph GJ;
Nat Immunol; 2012 Nov; 13(11):1118-28. PubMed ID: 23023392
[TBL] [Abstract][Full Text] [Related]
40. The chemokine system in diverse forms of macrophage activation and polarization.
Mantovani A; Sica A; Sozzani S; Allavena P; Vecchi A; Locati M
Trends Immunol; 2004 Dec; 25(12):677-86. PubMed ID: 15530839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
